S&P 500   4,068.57 (+0.44%)
DOW   33,014.29 (+0.47%)
QQQ   316.10 (+0.13%)
AAPL   162.16 (-0.12%)
MSFT   284.35 (+0.11%)
META   207.28 (-0.27%)
GOOGL   100.85 (-0.04%)
AMZN   102.18 (+0.18%)
TSLA   197.00 (+0.88%)
NVDA   272.00 (-0.67%)
NIO   10.34 (-1.15%)
BABA   102.49 (-0.86%)
AMD   97.32 (-0.57%)
T   19.12 (+0.21%)
F   12.39 (+0.81%)
MU   60.73 (-3.74%)
CGC   1.78 (+1.14%)
GE   94.36 (+0.33%)
DIS   98.85 (+0.76%)
AMC   4.98 (+0.20%)
PFE   40.41 (+0.07%)
PYPL   74.59 (+0.27%)
NFLX   342.80 (+1.29%)
S&P 500   4,068.57 (+0.44%)
DOW   33,014.29 (+0.47%)
QQQ   316.10 (+0.13%)
AAPL   162.16 (-0.12%)
MSFT   284.35 (+0.11%)
META   207.28 (-0.27%)
GOOGL   100.85 (-0.04%)
AMZN   102.18 (+0.18%)
TSLA   197.00 (+0.88%)
NVDA   272.00 (-0.67%)
NIO   10.34 (-1.15%)
BABA   102.49 (-0.86%)
AMD   97.32 (-0.57%)
T   19.12 (+0.21%)
F   12.39 (+0.81%)
MU   60.73 (-3.74%)
CGC   1.78 (+1.14%)
GE   94.36 (+0.33%)
DIS   98.85 (+0.76%)
AMC   4.98 (+0.20%)
PFE   40.41 (+0.07%)
PYPL   74.59 (+0.27%)
NFLX   342.80 (+1.29%)
S&P 500   4,068.57 (+0.44%)
DOW   33,014.29 (+0.47%)
QQQ   316.10 (+0.13%)
AAPL   162.16 (-0.12%)
MSFT   284.35 (+0.11%)
META   207.28 (-0.27%)
GOOGL   100.85 (-0.04%)
AMZN   102.18 (+0.18%)
TSLA   197.00 (+0.88%)
NVDA   272.00 (-0.67%)
NIO   10.34 (-1.15%)
BABA   102.49 (-0.86%)
AMD   97.32 (-0.57%)
T   19.12 (+0.21%)
F   12.39 (+0.81%)
MU   60.73 (-3.74%)
CGC   1.78 (+1.14%)
GE   94.36 (+0.33%)
DIS   98.85 (+0.76%)
AMC   4.98 (+0.20%)
PFE   40.41 (+0.07%)
PYPL   74.59 (+0.27%)
NFLX   342.80 (+1.29%)
S&P 500   4,068.57 (+0.44%)
DOW   33,014.29 (+0.47%)
QQQ   316.10 (+0.13%)
AAPL   162.16 (-0.12%)
MSFT   284.35 (+0.11%)
META   207.28 (-0.27%)
GOOGL   100.85 (-0.04%)
AMZN   102.18 (+0.18%)
TSLA   197.00 (+0.88%)
NVDA   272.00 (-0.67%)
NIO   10.34 (-1.15%)
BABA   102.49 (-0.86%)
AMD   97.32 (-0.57%)
T   19.12 (+0.21%)
F   12.39 (+0.81%)
MU   60.73 (-3.74%)
CGC   1.78 (+1.14%)
GE   94.36 (+0.33%)
DIS   98.85 (+0.76%)
AMC   4.98 (+0.20%)
PFE   40.41 (+0.07%)
PYPL   74.59 (+0.27%)
NFLX   342.80 (+1.29%)
NYSE:IMAX

IMAX - IMAX Price Target & Analyst Ratings

$18.70
+0.06 (+0.32%)
(As of 03/30/2023 12:00 AM ET)
Add
Compare
Today's Range
$18.61
$18.98
50-Day Range
$16.18
$19.04
52-Week Range
$12.13
$20.50
Volume
392,478 shs
Average Volume
541,296 shs
Market Capitalization
$1.01 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.63

IMAX Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 9 Analyst Ratings

Consensus Analyst Price Target

$20.63
10.29% Upside
High Prediction$25.00
Average Prediction$20.63
Low Prediction$14.00
TypeCurrent
3/31/22 to 3/31/23
1 Month Ago
3/1/22 to 3/1/23
3 Months Ago
12/31/21 to 12/31/22
1 Year Ago
3/31/21 to 3/31/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
7 Buy rating(s)
6 Buy rating(s)
7 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$20.63$20.63$20.86$25.18
Predicted Upside10.29% Upside27.83% Upside41.98% Upside30.30% Upside
Get IMAX Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for IMAX and its competitors with MarketBeat's FREE daily newsletter.

IMAX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

IMAX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

IMAX Stock vs. The Competition

TypeIMAXConsumer Discretionary CompaniesS&P 500
Consensus Rating Score
2.67
2.51
2.47
Consensus RatingModerate BuyBuyHold
Predicted Upside10.29% Upside85.40% Upside93.70% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/28/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSell$12.00 ➝ $14.00-23.41%
2/24/2023Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$20.00 ➝ $22.00+22.77%
2/23/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$16.00 ➝ $19.00+7.89%
2/23/2023Rosenblatt Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$22.00 ➝ $25.00+46.71%
2/13/2023Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
E. Handler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
12/5/2022B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$20.00 ➝ $23.00+29.80%
11/1/2022Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform$20.00+55.40%
11/1/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$26.00 ➝ $21.00+64.96%
10/6/2022Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$25.00 ➝ $21.00+39.44%
7/26/2021Colliers Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Steve Frankel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy$22.00+28.50%
4/30/2021Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$25.00 ➝ $30.00+40.98%
2/1/2021MKM Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$18.00 ➝ $25.00+28.73%
(Data available from 3/31/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












IMAX Price Target - Frequently Asked Questions

What is IMAX's consensus rating and price target?

According to the issued ratings of 9 analysts in the last year, the consensus rating for IMAX stock is Moderate Buy based on the current 1 sell rating, 1 hold rating and 7 buy ratings for IMAX. The average twelve-month price prediction for IMAX is $20.63 with a high price target of $25.00 and a low price target of $14.00. Learn more on IMAX's analyst rating history.

Do Wall Street analysts like IMAX more than its competitors?

Analysts like IMAX more than other Consumer Discretionary companies. The consensus rating for IMAX is Moderate Buy while the average consensus rating for consumer discretionary companies is Buy. Learn more on how IMAX compares to other companies.

Does IMAX's stock price have much upside?

According to analysts, IMAX's stock has a predicted upside of 27.83% based on their 12-month price targets.

What analysts cover IMAX?

Stock Ratings Reports and Tools

This page (NYSE:IMAX) was last updated on 3/31/2023 by MarketBeat.com Staff